OR WAIT null SECS
Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.
Vetter, a contract development and manufacturing organization (CDMO) that specializes in aseptic filling, has announced that the company has added a staff shift for daily clinical manufacturing operations, and doubled capacities for visual inspection and in-process control at its Skokie, IL facility.
The facility now offers the option secondary packaging services for small batches of frozen drug products such as vial labeling, cartoning, and carton labeling. A long-term collaboration with Sentry BioPharma Services, a provider of cGMP clinical packaging solutions and supply chain management, supports a streamlined path from filling to clinic, the company reports.
Vetter offers manufacturing resources from early drug development through to market launch and commercial supply. The sites in the United States and Europe use similar equipment and processes, including product contact materials such as excipients and primary packaging materials. This flexible approach results in less overall risk of unforeseen manufacturing issues, and creates a consistency between clinical and commercial drug product handling, the company reports.
To date, four customer products in development have already been successfully transferred from Vetter’s US clinical manufacturing facility to the company’s European sites for manufacturing of late-stage clinical supply and for subsequent commercial production.